Using organ-specific preparations, we enable you to take the next step into the future of patient-specific cancer diagnosis and optimized cancer therapy. The formulation of the kits we offer makes the synthesis of the ready-to-use product quick and easy.
Nuclear Medicine
Targeted molecular radiotherapy
Lutetium 177 (Lu-177) chlorid
n.c.a (non carrier added) | custom vial | weekly availability
Isotopia Molecular Imaging Ltd. (“Isotopia”) is a unique nuclear pharmacy established in Israel since 2006, and has become an essential supplier for the growing field of nuclear medicine in Israel.
Isotopia, founded by a highly trained group of senior professionals, experienced in all aspects of radiopharmacy operations, in collaboration with a group of Canadian investors.
Nowadays, Isotopia is taking steps for becoming a major worldwide supplier of Lu-177 to be used in the field of molecular radiotherapy.
Our aim is to supply Lu -177 according to costumers needs. By producing Lu-177 C.A and Lu-177 N.C.A, we can provide you both products according to your needs, tailor-made.
Key Advantages:
- Continuous supply of Lu-177 C.A guaranteed due to cooperation with
various nuclear reactors. - Availability- on a weekly basis all year round
- You choose your volume (fixed concentration)
- V Shaped for minimum material loss .
- Each lot is tested for labeling efficiency
Ordering Process
3 simple Steps: just define
Get Lu 177 according to your needs
Product Specifications
Lutetium 177 (Lu-177) chlorid
| Radionuclide | 177LU Lutetium Chloride Solution |
| Half-life | 6.65 days |
| Decay Mode | Beta decay |
| Chemical form | LuCl3 in 0.04 HCI |
| Test | c.a. | n.c.a |
| Appearance | Clear, colorless solution | Clear, colorless solution |
| pH | 1.0 — 2.0 | 1.0 — 2.0 |
| Identification | Gamma photons with 208 KeV and 113 KeV present | Gamma photons with 208 KeV and 113 KeV present |
| Specific Activity (by ICP-OES at end of production) | >740 GBq/mg (>20 Ci/mg) | >3,000 GBq/mg |
| Chemical Purity (by ICP-OES) | Cu ≤ 1.0 μg/GBq Fe ≤ 0.5 μg/GBq Pb ≤ 0.5 μg/GBq Zn ≤ 1.0 μg/GBq | Cu ≤1.0 μg/GBq Fe ≤0.5 μg/GBq Pb ≤0.5 μg/GBq Zn ≤1.0 μg/GBq 176Yb≤1.0 μg/GBq |
| Radionuclidic Purity (Gamma spectrometry) | 177mLu <0.07% | 175Yb < 0.1% |
| The total radioactivity due to other radionuclidic impurities < 0.01% | The total radioactivity due to other radionuclidic impurities < 0.01% |
|
| Radiochemical Purity (by iTLC) | [177Lu]lutetium(III) ion > 99% | [177Lu]lutetium(III) ion > 99% |
| Bacterial Endotoxins | 35 < EU/ml | 35 < EU/ml |
| Sterility | Retrospectively tested after decay |